172 related articles for article (PubMed ID: 32543350)
1. Disruption of TFIIH activities generates a stress gene expression response and reveals possible new targets against cancer.
Uriostegui-Arcos M; Aguayo-Ortiz R; Valencia-Morales MDP; Melchy-Pérez E; Rosenstein Y; Dominguez L; Zurita M
Open Biol; 2020 Jun; 10(6):200050. PubMed ID: 32543350
[TBL] [Abstract][Full Text] [Related]
2. XPB, a subunit of TFIIH, is a target of the natural product triptolide.
Titov DV; Gilman B; He QL; Bhat S; Low WK; Dang Y; Smeaton M; Demain AL; Miller PS; Kugel JF; Goodrich JA; Liu JO
Nat Chem Biol; 2011 Mar; 7(3):182-8. PubMed ID: 21278739
[TBL] [Abstract][Full Text] [Related]
3. Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44.
Yi JM; Huan XJ; Song SS; Zhou H; Wang YQ; Miao ZH
Mol Cancer Ther; 2016 Jul; 15(7):1495-503. PubMed ID: 27197304
[TBL] [Abstract][Full Text] [Related]
4. The genetic depletion or the triptolide inhibition of TFIIH in p53-deficient cells induces a JNK-dependent cell death in Drosophila.
Villicaña C; Cruz G; Zurita M
J Cell Sci; 2013 Jun; 126(Pt 11):2502-15. PubMed ID: 23549790
[TBL] [Abstract][Full Text] [Related]
5. Stably paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor triptolide.
Chen F; Gao X; Shilatifard A
Genes Dev; 2015 Jan; 29(1):39-47. PubMed ID: 25561494
[TBL] [Abstract][Full Text] [Related]
6. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1.
Dai H; Jiang Y; Luo Y; Bie P; Chen Z
Phytomedicine; 2019 Sep; 62():152953. PubMed ID: 31128486
[TBL] [Abstract][Full Text] [Related]
7. The effects of TPL-PEI-CyD on suppressing performance of MCF-7 stem cells.
Zhu Y; Xu F
Pak J Pharm Sci; 2020 Mar; 33(2(Supplementary)):835-838. PubMed ID: 32863259
[TBL] [Abstract][Full Text] [Related]
8. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S
Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170
[TBL] [Abstract][Full Text] [Related]
9. The essential and multifunctional TFIIH complex.
Rimel JK; Taatjes DJ
Protein Sci; 2018 Jun; 27(6):1018-1037. PubMed ID: 29664212
[TBL] [Abstract][Full Text] [Related]
10. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
[TBL] [Abstract][Full Text] [Related]
11. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
[TBL] [Abstract][Full Text] [Related]
12. How to limit the speed of a motor: the intricate regulation of the XPB ATPase and translocase in TFIIH.
Kappenberger J; Koelmel W; Schoenwetter E; Scheuer T; Woerner J; Kuper J; Kisker C
Nucleic Acids Res; 2020 Dec; 48(21):12282-12296. PubMed ID: 33196848
[TBL] [Abstract][Full Text] [Related]
13. Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes.
Jiang N; Dong XP; Zhang SL; You QY; Jiang XT; Zhao XG
Mol Med Rep; 2016 Jan; 13(1):153-9. PubMed ID: 26531258
[TBL] [Abstract][Full Text] [Related]
14. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
Li H; Takai N; Yuge A; Furukawa Y; Tsuno A; Tsukamoto Y; Kong S; Moriyama M; Narahara H
Cancer Lett; 2010 Nov; 297(2):198-206. PubMed ID: 20547442
[TBL] [Abstract][Full Text] [Related]
15. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
Liu Y; Xiao E; Yuan L; Li G
DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
[TBL] [Abstract][Full Text] [Related]
16. Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs.
Huang X; Yang M; Jin J
Leuk Lymphoma; 2012 Jun; 53(6):1188-95. PubMed ID: 22260163
[TBL] [Abstract][Full Text] [Related]
17. Triptolide (TPL) inhibits global transcription by inducing proteasome-dependent degradation of RNA polymerase II (Pol II).
Wang Y; Lu JJ; He L; Yu Q
PLoS One; 2011; 6(9):e23993. PubMed ID: 21931633
[TBL] [Abstract][Full Text] [Related]
18. Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo.
Shi Y; Zhao H; Ye J; Li Z; Deng M; Zha J; Zhou Y; Zeng H; Lin Y; Pu X; Guo C; Song H; Qiu Y; Xu B
Mol Carcinog; 2020 Sep; 59(9):1076-1087. PubMed ID: 32691884
[TBL] [Abstract][Full Text] [Related]
19. p52 Mediates XPB function within the transcription/repair factor TFIIH.
Jawhari A; Lainé JP; Dubaele S; Lamour V; Poterszman A; Coin F; Moras D; Egly JM
J Biol Chem; 2002 Aug; 277(35):31761-7. PubMed ID: 12080057
[TBL] [Abstract][Full Text] [Related]
20. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
